59P-26397-51527
2 vaccinations
3 coded responses
23 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 191 / PA
- Registered
- 2021-09-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
F5Y-20706-82569
Child or adolescent in my care · Female · 2022-09-17
Timeline
-
2021-09-01
Dose 1 — Pfizer-BioNTech
-
2021-09-02
Registered in v-safe
-
2021-09-02
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-09-03
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-07
- 2021-09-08
- 2021-09-15
-
2021-09-22
Dose 2 — Pfizer-BioNTech
- 2021-09-22
-
2021-09-23
Survey response — days 1–6 daily, dose 2MedDRA: Muscle spasms — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Leg crampsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-09-26
- 2021-09-27
- 2021-09-28
- 2021-09-29
- 2021-10-06
- 2021-10-13
- 2021-10-20
-
2021-10-27
Survey response — day 35, dose 2MedDRA: Cough, Nasal congestion — Feeling: GoodFree text: Stuffy nose, occasional coughMedDRA releases: 2024-11 · check-in free text available
- 2021-11-03
-
2021-12-22
Survey response — 3 months, dose 2MedDRA: Delivery, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Preeclampsia, gave birthMedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2021-12-23
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-03-25
- 2022-09-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-01 | Pfizer-BioNTech | No |
| 2 | 2021-09-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-22 | Successful 2021-12-23 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Leg cramps
Release 10 — day 35, dose 2
Symptoms: Stuffy nose, occasional cough
Release 10 — 3 months, dose 2
Symptoms: Preeclampsia, gave birth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Muscle spasms | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release